Home The Word Brain	My Amedeo FAQ Privacy About
	2049 Chinese The 20K Word Road to Mandarin Proficiency By B. S. Kamps et al.

Head and Neck Cancer

Free Subscription Articles published in Int J Radiat Oncol Biol Phys Retrieve available abstracts of 275 articles: HTML format

Single Articles

April 2024
1. SMITH J, Margalit D, Golledge J, Nastasi D, et al
   Carotid Artery Stenosis and Ischemic Stroke in Patients with Head and Neck Cancer Treated with Radiotherapy: A Critical Review.
   Int J Radiat Oncol Biol Phys. 2024 Apr 5:S0360-3016(24)00474.
   PubMed     Abstract available
   
   
   
2. HIROSE K, Sato M
   Clinical Results and Prognostic Factors in BNCT for Recurrent Squamous Cell Carcinoma of the Head and Neck under the Japan National Health Insurance System: A Retrospective Study of the Initial 47 Patients.
   Int J Radiat Oncol Biol Phys. 2024 Apr 3:S0360-3016(24)00466.
   PubMed     Abstract available
   
   
   
3. HOMMA A, Mikami M, Matsuura K, Onimaru R, et al
   Dose-Finding and Efficacy Confirmation Trial of the Superselective Intra-arterial Infusion of Cisplatin and Concomitant Radiation Therapy for Locally Advanced Maxillary Sinus Cancer (JCOG1212): Results of the Efficacy Confirmation Phase in Patients wi
   Int J Radiat Oncol Biol Phys. 2024;118:1271-1281.
   PubMed     Abstract available
   
   
   
4. BUDRUKKAR A, Murthy V, Kashid S, Swain M, et al
   Intensity-Modulated Radiation Therapy Alone Versus Intensity-Modulated Radiation Therapy and Brachytherapy for Early-Stage Oropharyngeal Cancers: Results From a Randomized Controlled Trial.
   Int J Radiat Oncol Biol Phys. 2024;118:1541-1551.
   PubMed     Abstract available
   
   
   March 2024
5. YOUSSEF I, Mohamed N, Kallini D, Zakeri K, et al
   An Analysis of PET Maximum SUV Among Head and Neck Cancer Patients Receiving Photon and Proton Radiation.
   Int J Radiat Oncol Biol Phys. 2024 Mar 16:S0360-3016(24)00428.
   PubMed     Abstract available
   
   
   
6. CHEN M, Wang K, Wang J
   Vision Transformer-Based Multilabel Survival Prediction for Oropharynx Cancer After Radiation Therapy.
   Int J Radiat Oncol Biol Phys. 2024;118:1123-1134.
   PubMed     Abstract available
   
   
   
7. DENG J, Dietrich MS, Aulino JM, Sinard RJ, et al
   Longitudinal Pattern of Lymphedema and Fibrosis in Patients With Oral Cavity or Oropharyngeal Cancer: A Prospective Study.
   Int J Radiat Oncol Biol Phys. 2024;118:1029-1040.
   PubMed     Abstract available
   
   
   
8. MCDOWELL L, Gough K, Fua T, Coleman A, et al
   A Longitudinal Study Evaluating Sexual Health Outcomes and Prioritization in Patients Undergoing Chemoradiation for Human Papillomavirus-Associated Oropharyngeal Cancer.
   Int J Radiat Oncol Biol Phys. 2024;118:1018-1028.
   PubMed     Abstract available
   
   
   
9. MOWERY YM
   Cautionary Tale: Excess Toxicity With DNA-Dependent Protein Kinase Inhibitor and Concurrent Cisplatin-Based Chemoradiation for Head and Neck Cancer.
   Int J Radiat Oncol Biol Phys. 2024;118:757-758.
   PubMed    
   
   
   
10. SAMUELS M, Falkenius J, Bar-Ad V, Dunst J, et al
    A Phase 1 Study of the DNA-PK Inhibitor Peposertib in Combination With Radiation Therapy With or Without Cisplatin in Patients With Advanced Head and Neck Tumors.
    Int J Radiat Oncol Biol Phys. 2024;118:743-756.
    PubMed     Abstract available
    
    
    
11. ZHANG S, Li K, Sun Y, Wan Y, et al
    Deep learning for automatic gross tumor volumes contouring in esophageal cancer based on contrast-enhanced CT images: a multi-institutional study.
    Int J Radiat Oncol Biol Phys. 2024 Mar 1:S0360-3016(24)00350.
    PubMed     Abstract available
    
    
    February 2024
12. DE BRUYCKER A, De Neve W, Daisne JF, Vercauteren T, et al
    Disease control and late toxicity in Adaptive Dose Painting by Numbers vs. non-adaptive radiotherapy for head and neck cancer: a randomized controlled phase II trial.
    Int J Radiat Oncol Biol Phys. 2024 Feb 20:S0360-3016(24)00025.
    PubMed     Abstract available
    
    
    
13. ADAM DP, Grudzinski JJ, Marsh IR, Hill PM, et al
    Voxel-level dosimetry for combined Iodine-131 radiopharmaceutical therapy and external beam radiotherapy treatment paradigms of head and neck cancer.
    Int J Radiat Oncol Biol Phys. 2024 Feb 15:S0360-3016(24)00308.
    PubMed     Abstract available
    
    
    
14. BRITTON B, Baker AL, Wolfenden L, Wratten C, et al
    Five-year mortality outcomes for Eating As Treatment (EAT), a health behaviour change intervention to improve nutrition in patients with head and neck cancer: a stepped-wedge, randomised controlled trial.
    Int J Radiat Oncol Biol Phys. 2024 Feb 4:S0360-3016(24)00248.
    PubMed     Abstract available
    
    
    
15. GLASER S
    Nodal Recurrence of Uterine Cancer: A Growing Problem.
    Int J Radiat Oncol Biol Phys. 2024;118:319.
    PubMed    
    
    
    
16. LOUATI S, Wozny AS, Malesys C, Daguenet E, et al
    Differential Formation of Stress Granules in Radiosensitive and Radioresistant Head and Neck Squamous Cell Carcinoma Cells.
    Int J Radiat Oncol Biol Phys. 2024;118:485-497.
    PubMed     Abstract available
    
    
    January 2024
17. HUISKES M, Kong W, Oud M, Crama K, et al
    Validation of Fully Automated Robust Multicriterial Treatment Planning for Head and Neck Cancer IMPT.
    Int J Radiat Oncol Biol Phys. 2024 Jan 27:S0360-3016(23)08308.
    PubMed     Abstract available
    
    
    
18. HAHN E, Huang SH
    Leveraging the Potential of Induction Therapy in Human Papillomavirus-Mediated Oropharyngeal Carcinoma.
    Int J Radiat Oncol Biol Phys. 2024;118:179-181.
    PubMed    
    
    
    
19. LESTER SC, Moon DH, Patel SH, Awan MJ, et al
    Leave No Cancer Behind: The Conformal Hypofractionation Era and Head and Neck Cancer.
    Int J Radiat Oncol Biol Phys. 2024;118:165-168.
    PubMed    
    
    
    
20. XU T, Shen C, Zhou X, Zhu L, et al
    Selective Treatment Deintensification by Reducing Radiation Dose and Omitting Concurrent Chemotherapy Based on Response to Induction Chemotherapy in Human Papillomavirus-Associated Oropharyngeal Squamous Cell Carcinoma: A Single-Arm, Phase 2 Trial (IC
    Int J Radiat Oncol Biol Phys. 2024;118:169-178.
    PubMed     Abstract available
    
    
    
21. MERCADANTE V, Hamad AA, McCaul J, Nutting C, et al
    Salivary Electrostimulation in the Treatment of Radiation Therapy-Induced Xerostomia (LEONIDAS-2): A Multicenter, Randomized, Double-Masked, Sham-Controlled, Phase 3 Trial.
    Int J Radiat Oncol Biol Phys. 2024;118:142-153.
    PubMed     Abstract available
    
    
    December 2023
22. HANNA GJ, Chang SS, Siddiqui F, Bain PA, et al
    Imaging and Biomarker Surveillance for Head and Neck Squamous cell carcinoma: A Systematic Review and Appropriate Use Criteria Document.
    Int J Radiat Oncol Biol Phys. 2023 Dec 31:S0360-3016(23)08258.
    PubMed     Abstract available
    
    
    
23. DUAN Y, Wang J, Wu P, Chen H, et al
    AS-NeSt: a Novel 3D Deep Learning Model for Radiotherapy Dose Distribution Prediction on Esophageal Cancer Treatment with Multiple Prescriptions.
    Int J Radiat Oncol Biol Phys. 2023 Dec 28:S0360-3016(23)08239.
    PubMed     Abstract available
    
    
    
24. ODHIAMBO DA, Pittman AN, Rickard AG, Castillo RJ, et al
    Preclinical Evaluation of the ATR inhibitor BAY 1895344 as a Radiosensitizer for Head and Neck Squamous Cell Carcinoma.
    Int J Radiat Oncol Biol Phys. 2023 Dec 15:S0360-3016(23)08244.
    PubMed     Abstract available
    
    
    
25. THOMSON PD, Slevin PN, Baines H, Betts G, et al
    Randomised phase III trial of the hypoxia modifier nimorazole added to radiotherapy with benefit assessed in hypoxic head and neck cancers determined using a gene signature (NIMRAD).
    Int J Radiat Oncol Biol Phys. 2023 Dec 8:S0360-3016(23)08184.
    PubMed     Abstract available
    
    
    
26. KODAIRA T, Kagami Y, Machida R, Shikama N, et al
    Long-Term Follow-up of a Randomized Controlled Trial on Accelerated Radiation Therapy Versus Standard Fractionated Radiation Therapy for Early Glottic Cancer (JCOG0701A3).
    Int J Radiat Oncol Biol Phys. 2023;117:1118-1124.
    PubMed     Abstract available
    
    
    
27. KYAW JYA, Rendall A, Gillespie EF, Roques T, et al
    Systematic Review and Meta-analysis of the Association Between Radiation Therapy Treatment Volume and Patient Outcomes.
    Int J Radiat Oncol Biol Phys. 2023;117:1063-1086.
    PubMed     Abstract available
    
    
    November 2023
28. HAHN E, Ng WT
    Small Changes, Big Impact: Excitement and Caution in Dose and Volume Reduction for Nasopharyngeal Carcinoma Radiation Therapy After Induction Chemotherapy.
    Int J Radiat Oncol Biol Phys. 2023;117:925-927.
    PubMed    
    
    
    
29. VASQUEZ OSORIO E, Abravan A, Green A, van Herk M, et al
    Dysphagia at 1 Year is Associated With Mean Dose to the Inferior Section of the Brain Stem.
    Int J Radiat Oncol Biol Phys. 2023;117:903-913.
    PubMed     Abstract available
    
    
    
30. RAZAVIAN NB, D'Agostino RB Jr, Shenker RF, Hughes RT, et al
    Intensity-Modulated Radiation Therapy for Early-Stage Squamous Cell Carcinoma of the Glottic Larynx: A Systematic Review and Meta-Analysis.
    Int J Radiat Oncol Biol Phys. 2023;117:652-663.
    PubMed     Abstract available
    
    
    October 2023
31. RUHLE A, Weymann M, Behrens M, Marschner S, et al
    A Multicenter Evaluation of Different Chemotherapy Regimens in Older Adults With Head and Neck Squamous Cell Carcinoma Undergoing Definitive Chemoradiation.
    Int J Radiat Oncol Biol Phys. 2023 Oct 30:S0360-3016(23)08025.
    PubMed     Abstract available
    
    
    
32. RINGASH J, Dunphy C, Avery L, Chahin R, et al
    Efficacy of the rehabilitation planning consult for survivors of head and neck cancer: A phase II randomized controlled trial.
    Int J Radiat Oncol Biol Phys. 2023 Oct 9:S0360-3016(23)07957.
    PubMed     Abstract available
    
    
    
33. DUPERE JM, Lucido JJ, Breen WG, Mahajan A, et al
    Pencil beam scanning proton therapy for pregnant patients with brain and head and neck cancers.
    Int J Radiat Oncol Biol Phys. 2023 Oct 9:S0360-3016(23)07953.
    PubMed     Abstract available
    
    
    
34. SCHOENFELD JD
    Proceed With Caution: Eliminating Elective Nodal Irradiation With Immunotherapy for Head and Neck Cancer.
    Int J Radiat Oncol Biol Phys. 2023;117:355-356.
    PubMed    
    
    
    
35. MA TM, Wong DJ, Chai-Ho W, Mendelsohn A, et al
    High Recurrence for HPV-Positive Oropharyngeal Cancer With Neoadjuvant Radiation Therapy to Gross Disease Plus Immunotherapy: Analysis From a Prospective Phase Ib/II Clinical Trial.
    Int J Radiat Oncol Biol Phys. 2023;117:348-354.
    PubMed    
    
    
    
36. GARDEN AS, Harris J, Eisbruch A, Chao KSC, et al
    Final Report of NRG Oncology RTOG 0022: A Phase 1/2 Study of Conformal and Intensity Modulated Radiation for Oropharyngeal Cancer.
    Int J Radiat Oncol Biol Phys. 2023;117:333-340.
    PubMed    
    
    
    September 2023
37. MOWERY YM
    Splitting the Difference With Intensified Radiation Therapy Alone for Borderline Early Stage Glottic Cancer.
    Int J Radiat Oncol Biol Phys. 2023;117:9.
    PubMed    
    
    
    
38. DE LEO AN, Dagan R
    Early Glottic Cancer With Adverse Features: Can Larynx-Only RT Cut It Without Needing to Eventually Cut It Out?
    Int J Radiat Oncol Biol Phys. 2023;117:6-7.
    PubMed    
    
    
    
39. ALLEN SG, Rosen BS, Aryal M, Cao Y, et al
    Initial Feasibility and Acute Toxicity Outcomes From a Phase 2 Trial of (18)F-Fluorodeoxyglucose Positron Emission Tomography Response-Based De-escalated Definitive Chemoradiotherapy for p16+ Oropharynx Cancer: A Planned Interim Analysis.
    Int J Radiat Oncol Biol Phys. 2023;117:171-180.
    PubMed     Abstract available
    
    
    August 2023
40. WANG X, van Rossum PSN, Chu Y, Hobbs BP, et al
    Severe Lymphopenia During Chemoradiation Therapy for Esophageal Cancer: Comprehensive Analysis of Randomized Phase IIB Trial of Proton Beam Therapy Versus Intensity-Modulated Radiation Therapy.
    Int J Radiat Oncol Biol Phys. 2023 Aug 29:S0360-3016(23)07852.
    PubMed     Abstract available
    
    
    
41. 
    Erratum to: Caudell JJ, Torres-Saavedra PA, Rosenthal DI, Axelrod RS, et al. Long-Term Update of NRG/RTOG 0522: A Randomized Phase 3 Trial of Concurrent Radiation and Cisplatin With or Without Cetuximab in Locoregionally Advanced Head and Neck Cancer.
    Int J Radiat Oncol Biol Phys. 2023 Aug 11:S0360-3016(23)07642.
    PubMed    
    
    
    
42. MILLER ED, Wu T, McKinley G, Slivnick J, et al
    Incident Atrial Fibrillation and Survival Outcomes in Esophageal Cancer following Radiotherapy.
    Int J Radiat Oncol Biol Phys. 2023 Aug 11:S0360-3016(23)07748.
    PubMed     Abstract available
    
    
    
43. MCDOWELL L, Bressel M, King MT, Corry J, et al
    Patient-Reported Symptom Severity, Health-Related Quality of Life, and Emotional Distress Trajectories During and After Radiation Therapy for Human Papillomavirus-Associated Oropharyngeal Cancer: A TROG 12.01 Secondary Analysis.
    Int J Radiat Oncol Biol Phys. 2023;116:1110-1125.
    PubMed     Abstract available
    
    
    July 2023
44. BONOMI M, Blakaj DM, Kabarriti R, Colvett K, et al
    PREVLAR: Phase 2a Randomized Trial to Assess the Safety and Efficacy of RRx-001 in the Attenuation of Oral Mucositis in Patients Receiving Head and Neck Chemoradiotherapy.
    Int J Radiat Oncol Biol Phys. 2023;116:551-559.
    PubMed     Abstract available
    
    
    June 2023
45. MOON DH, Avkshtol V, Vo D, Ahn C, et al
    HYPORT: Phase I study of three-week hypofractionated post-operative radiation therapy for head and neck squamous cell carcinoma.
    Int J Radiat Oncol Biol Phys. 2023 Jun 26:S0360-3016(23)00600.
    PubMed     Abstract available
    
    
    
46. XIANG L, Rong JF, Chen X, Li XY, et al
    Reducing Target Volumes of Intensity-Modulated Radiotherapy Following Induction Chemotherapy in Locoregionally Advanced Nasopharyngeal Carcinoma: Long-Term Results of a Prospective, Multicenter, Randomized Trial.
    Int J Radiat Oncol Biol Phys. 2023 Jun 23:S0360-3016(23)00585.
    PubMed     Abstract available
    
    
    
47. YANG Y, Feng T, Fan X, Wang C, et al
    Genomic and transcriptomic remodelling by neoadjuvant chemoradiotherapy (nCRT) and indicative role of acquired INDEL percentage for nCRT efficacy in esophageal squamous cell carcinoma.
    Int J Radiat Oncol Biol Phys. 2023 Jun 18:S0360-3016(23)00588.
    PubMed     Abstract available
    
    
    May 2023
48. HENG J, Li Z, Liu L, Zheng Z, et al
    Acetyl-CoA Acetyltransferase 2 Confers Radioresistance by Inhibiting Ferroptosis in Esophageal Squamous Cell Carcinoma.
    Int J Radiat Oncol Biol Phys. 2023 May 25:S0360-3016(23)00519.
    PubMed     Abstract available
    
    
    
49. PAPE M, Veen LM, Smit TM, Kuijper SC, et al
    Late toxicity and health-related quality of life following definitive chemoradiotherapy for esophageal cancer: a systematic review and meta-analysis.
    Int J Radiat Oncol Biol Phys. 2023 May 22:S0360-3016(23)00512.
    PubMed     Abstract available
    
    
    
50. GAO T, Yang Y, Zhang Z, Yang Y, et al
    A Surrogate Endpoint for Overall Survival in Locally Advanced and Resectable Esophageal Squamous Cell Carcinoma: a Re-analysis of Data from the NEOCRTEC5010 Trial.
    Int J Radiat Oncol Biol Phys. 2023 May 18:S0360-3016(23)00497.
    PubMed     Abstract available
    
    
    
51. VAN RIJN DEKKER MI, van Luijk P, Schuit E, van der Schaaf A, et al
    Prediction of radiation-induced parotid gland-related xerostomia in head and neck cancer patients: regeneration-weighted dose.
    Int J Radiat Oncol Biol Phys. 2023 May 5:S0360-3016(23)00437.
    PubMed     Abstract available
    
    
    
52. DIAO K, Lei X, Smith GL, Jagsi R, et al
    Patient-Reported Financial Toxicity in a Population-Based Cohort of Oropharynx Cancer Survivors.
    Int J Radiat Oncol Biol Phys. 2023;116:142-153.
    PubMed     Abstract available
    
    
    
53. DAR MA, Chauhan R, Trivedi V, Kumar R, et al
    Assessing the Prevalence of Financial Toxicity, its Predictors and Association with Health- Related Quality of Life Among Radiation Oncology Patients in India: A Cross-Sectional Patient Reported Outcome Study.
    Int J Radiat Oncol Biol Phys. 2023;116:157-165.
    PubMed     Abstract available
    
    
    April 2023
54. ISOZAKI T, Ishikawa H, Yasuda S, Isozaki Y, et al
    A Phase I/II Trial of Definitive Carbon Ion Radiotherapy for Clinical T1bN0M0 Esophageal Squamous Cell Carcinoma.
    Int J Radiat Oncol Biol Phys. 2023 Apr 26:S0360-3016(23)00378.
    PubMed     Abstract available
    
    
    
55. ECHEVARRIA MI, Yang GQ, Chen DT, Kirtane K, et al
    Phase I dose escalation of stereotactic body radiation therapy and concurrent cisplatin for re-irradiation of unresectable, recurrent squamous cell carcinoma of the head and neck.
    Int J Radiat Oncol Biol Phys. 2023 Apr 25:S0360-3016(23)00366.
    PubMed     Abstract available
    
    
    
56. ALI AS, Msanukian G, Johnson JM, Vathiotis I, et al
    In-field toxicity analysis of a phase I clinical trial of nivolumab and ipilimumab with definitive radiation therapy in locally advanced squamous cell carcinoma of the head and neck: In-Field toxicity of immune-RT in LA-SCCHN.
    Int J Radiat Oncol Biol Phys. 2023 Apr 3:S0360-3016(23)00309.
    PubMed     Abstract available
    
    
    
57. TAM A, Amini A
    Management After an Initial Nononcologic Approach to an HPV+ Head and Neck Cancer.
    Int J Radiat Oncol Biol Phys. 2023;115:1026.
    PubMed    
    
    
    
58. BEITLER JJ, Sen N
    T1N1M0 + p16 Squamous Cell Cancer of Base of Tongue With 3.6-cm Node and <1 mm of ENE.
    Int J Radiat Oncol Biol Phys. 2023;115:1027-1028.
    PubMed    
    
    
    
59. VAN BRUGGEN IG, Huiskes M, de Vette SPM, Holmstrom M, et al
    Automated Robust Planning for IMPT in Oropharyngeal Cancer Patients Using Machine Learning.
    Int J Radiat Oncol Biol Phys. 2023;115:1283-1290.
    PubMed     Abstract available
    
    
    
60. YANG SS, OuYang PY, Guo JG, Cai JJ, et al
    Dosiomics Risk Model for Predicting Radiation Induced Temporal Lobe Injury and Guiding Individual Intensity-Modulated Radiation Therapy.
    Int J Radiat Oncol Biol Phys. 2023;115:1291-1300.
    PubMed     Abstract available
    
    
    March 2023
61. BRISSON RJ, Holtzman AL
    Who Knows When it is Right Under Your Nose? A Case of Cutaneous Squamous Cell Carcinoma with Involvement of the Nasal Vestibule.
    Int J Radiat Oncol Biol Phys. 2023;115:817-818.
    PubMed    
    
    
    
62. MCDONALD MW, Bates JE, McCall NS, Goyal S, et al
    Insurance authorization and access to proton therapy for patients with head and neck cancers.
    Int J Radiat Oncol Biol Phys. 2023 Mar 6:S0360-3016(23)00178.
    PubMed     Abstract available
    
    
    January 2023
63. MA SJ, Iovoli AJ, Wang K, Neimanis D, et al
    Efficacy of Prophylactic High-Dose Gabapentin and Venlafaxine on Reducing Oral Mucositis Pain Among Patients Treated with Chemoradiation for Head and Neck Cancer: A Single-Institution, Phase II, Randomized Clinical Trial.
    Int J Radiat Oncol Biol Phys. 2023 Jan 31:S0360-3016(23)00084.
    PubMed     Abstract available
    
    
    
64. DING M, Cui H, Li B, Zou B, et al
    Integrating preoperative CT and clinical factors for lymph node metastasis prediction in esophageal squamous cell carcinoma (ESCC) by feature-wise attentional graph neural network (FAGNN).
    Int J Radiat Oncol Biol Phys. 2023 Jan 11:S0360-3016(23)00002.
    PubMed     Abstract available
    
    
    
65. WU Y, Qian Y
    Treatment for Radiation-Recall Mucositis Induced by Anti-PD-1 Blockade.
    Int J Radiat Oncol Biol Phys. 2023;115:7-8.
    PubMed    
    
    
    
66. SHERER MV, Sher DJ
    Patient-Reported Outcomes After Unilateral Treatment for Human Papillomavirus-Associated Tonsillar Cancer: Overrated or Still Overtreated?
    Int J Radiat Oncol Biol Phys. 2023;115:189-191.
    PubMed    
    
    
    
67. ANDERSON JD, DeWees TA, Ma DJ, Nagel TH, et al
    A Prospective Study of Mucosal Sparing Radiation Therapy in Resected Oropharyngeal Cancer Patients.
    Int J Radiat Oncol Biol Phys. 2023;115:192-201.
    PubMed     Abstract available
    
    
    
68. MCDOWELL L, Rischin D, King M, Kenny L, et al
    Patient- and Clinician-Reported Outcomes in Human Papillomavirus-Associated Tonsillar Carcinoma Treated With Unilateral and Bilateral Intensity Modulated Radiation Therapy-A Substudy From TROG 12.01.
    Int J Radiat Oncol Biol Phys. 2023;115:174-188.
    PubMed     Abstract available
    
    
    December 2022
69. HUANG CL, Qiu YY, Du XJ, Wang GY, et al
    Upper-neck versus whole-neck irradiation at the contralateral uninvolved neck in patients with unilateral N3 nasopharyngeal carcinoma.
    Int J Radiat Oncol Biol Phys. 2022 Dec 31:S0360-3016(22)03694.
    PubMed     Abstract available
    
    
    
70. CAUDELL JJ, Torres-Saavedra PA, Rosenthal DI, Axelrod RS, et al
    Long-term update of NRG/RTOG 0522: a randomized phase III trial of concurrent radiation and cisplatin with or without cetuximab in locoregionally advanced head and neck cancer.
    Int J Radiat Oncol Biol Phys. 2022 Dec 19:S0360-3016(22)03636.
    PubMed     Abstract available
    
    
    
71. FU S, Li Y, Han Y, Wang H, et al
    Erratum to: Diffusion-Weighted Magnetic Resonance Imaging-Guided Dose Painting in Patients With Locoregionally Advanced Nasopharyngeal Carcinoma Treated With Induction Chemotherapy Plus Concurrent Chemoradiotherapy: A Randomized, Controlled Clinical T
    Int J Radiat Oncol Biol Phys. 2022;114:1055-1056.
    PubMed    
    
    
    November 2022
72. QIAN DC, Ulrich BC, Peng G, Zhao H, et al
    Outcomes stratification of head and neck cancer using pre- and post-treatment DNA methylation from peripheral blood.
    Int J Radiat Oncol Biol Phys. 2022 Nov 18:S0360-3016(22)03521.
    PubMed     Abstract available
    
    
    
73. YOU J, Zhu S, Li J, Li J, et al
    High-dose versus standard-dose intensity-modulated radiotherapy with concurrent paclitaxel plus carboplatin for patients with thoracic esophageal squamous cell carcinoma: a randomized, multicenter, open-label, phase 3 superiority trial.
    Int J Radiat Oncol Biol Phys. 2022 Nov 16:S0360-3016(22)03520.
    PubMed     Abstract available
    
    
    
74. NAKAJIMA S, Mimura K, Kaneta A, Saito K, et al
    Radiation-induced remodeling of the tumor-microenvironment through tumor cell-intrinsic expression of cGAS-STING in esophageal squamous cell carcinoma.
    Int J Radiat Oncol Biol Phys. 2022 Nov 8. pii: S0360-3016(22)03512.
    PubMed     Abstract available
    
    
    
75. REYES EG, Tonse R, Chundru S, Kaiser A, et al
    Variable Relative Biological Effectiveness of Proton Therapy Increases PET Visible Mucosal Injury in Head and Neck Cancer Patients.
    Int J Radiat Oncol Biol Phys. 2022 Nov 8. pii: S0360-3016(22)03508.
    PubMed     Abstract available
    
    
    
76. SHARMA AK
    Adjuvant Head and Neck Radiation in a Young Pregnant Woman.
    Int J Radiat Oncol Biol Phys. 2022;114:382.
    PubMed    
    
    
    October 2022
77. GILLISON ML, Ferris RL, Harris J, Colevas AD, et al
    Safety of nivolumab added to chemoradiotherapy platforms for intermediate and high-risk local-regionally advanced head and neck squamous cell carcinoma: RTOG Foundation 3504.
    Int J Radiat Oncol Biol Phys. 2022 Oct 10. pii: S0360-3016(22)03434.
    PubMed     Abstract available
    
    
    
78. PRICE K, Van Abel KM, Moore EJ, Patel SH, et al
    Long-Term Toxic Effects, Swallow Function, and Quality of Life on MC1273: A Phase 2 Study of Dose De-escalation for Adjuvant Chemoradiation in Human Papillomavirus-Positive Oropharyngeal Cancer.
    Int J Radiat Oncol Biol Phys. 2022;114:256-265.
    PubMed     Abstract available
    
    
    September 2022
79. LI L, Sun J, Liu N, Yu R, et al
    Clinical Outcome-Related Cancer Pathways and Mutational Signatures in Patients With Unresectable Esophageal Squamous Cell Carcinoma Treated With Chemoradiotherapy.
    Int J Radiat Oncol Biol Phys. 2022 Sep 24. pii: S0360-3016(22)02594.
    PubMed     Abstract available
    
    
    
80. BEADLE BM, Bauman JE
    Reconsidering How It Begins: Response to Gray Zone Article About Head and Neck Cancer in a Young Pregnant Woman.
    Int J Radiat Oncol Biol Phys. 2022 Sep 21. pii: S0360-3016(22)03321.
    PubMed    
    
    
    
81. NELSON B, Takiar V
    Low Risk, High Risk: Adjuvant Therapy in Resected p16+ Oropharyngeal Cancer with >/=5 Positive Ipsilateral Lymph Nodes.
    Int J Radiat Oncol Biol Phys. 2022;114:10-11.
    PubMed    
    
    
    August 2022
82. CAI G, Li C, Li J, Yang J, et al
    Cardiac Substructures Dosimetric Predictors for Cardiac Toxicity After Definitive Radiotherapy in Esophageal Cancer.
    Int J Radiat Oncol Biol Phys. 2022 Aug 13. pii: S0360-3016(22)03105.
    PubMed     Abstract available
    
    
    
83. TAKEUCHI H, Ito Y, Machida R, Kato K, et al
    A Single-Arm Confirmatory Study of Definitive Chemoradiotherapy Including Salvage Treatment for Clinical Stage II/III Esophageal Squamous Cell Carcinoma (JCOG0909 Study).
    Int J Radiat Oncol Biol Phys. 2022 Aug 3. pii: S0360-3016(22)00726.
    PubMed     Abstract available
    
    
    
84. TAKU N, Chronowski G, Brandon Gunn G, Morrison WH, et al
    Unilateral Radiation Therapy for Tonsillar Cancer: Treatment Outcomes in the Era of Human Papillomavirus, Positron-Emission Tomography, and Intensity Modulated Radiation Therapy.
    Int J Radiat Oncol Biol Phys. 2022;113:1054-1062.
    PubMed     Abstract available
    
    
    July 2022
85. MOON DH, Sher DJ
    Oligometastasis in head and neck squamous cell carcinoma.
    Int J Radiat Oncol Biol Phys. 2022 Jul 4. pii: S0360-3016(22)00660.
    PubMed     Abstract available
    
    
    
86. BHIDE S
    Circulating Human Papillomavirus DNA as a Marker of Minimally Residual Disease After Surgery for Oropharyngeal Cancer.
    Int J Radiat Oncol Biol Phys. 2022;113:539-541.
    PubMed    
    
    
    
87. FNAIS N, Laxague F, Alzahrani F, Fung K, et al
    The Impact of Surgical Resectability on Outcomes for Patients Undergoing Primary Radiation Treatment for Human Papillomavirus-Related Oropharyngeal Cancer.
    Int J Radiat Oncol Biol Phys. 2022;113:521-529.
    PubMed     Abstract available
    
    
    
88. SHINYA Y, Hasegawa H, Shin M, Kawashima M, et al
    High Dose Radiosurgery Targeting the Primary Tumor Sites Contributes to Survival in Patients With Skull Base Chordoma.
    Int J Radiat Oncol Biol Phys. 2022;113:582-587.
    PubMed     Abstract available
    
    
    
89. ROUTMAN DM, Kumar S, Chera BS, Jethwa KR, et al
    Detectable Postoperative Circulating Tumor Human Papillomavirus DNA and Association with Recurrence in Patients With HPV-Associated Oropharyngeal Squamous Cell Carcinoma.
    Int J Radiat Oncol Biol Phys. 2022;113:530-538.
    PubMed     Abstract available
    
    
    June 2022
90. ANDERSON CM, Lee CM, Saunders D, Curtis AE, et al
    Two-Year Tumor Outcomes of Phase 2B, Randomized, Double-Blind Trial of Avasopasem Manganese (GC4419) Versus Placebo to Reduce Severe Oral Mucositis Due to Concurrent Radiation Therapy and Ciplatin for Head and Neck Cancer.
    Int J Radiat Oncol Biol Phys. 2022 Jun 17. pii: S0360-3016(22)00608.
    PubMed     Abstract available
    
    
    
91. TAYLOR CL, Price JM
    The Tooth Hurts: Dental Health After Radiation Therapy for Head and Neck Cancer.
    Int J Radiat Oncol Biol Phys. 2022;113:331-334.
    PubMed    
    
    
    
92. MCDOWELL L, Chua MLK, Beadle BM, Ma DJ, et al
    A Bit More Here and a Little Less There: The Trials (and Tribulations) of Adjuvant and Neoadjuvant Head and Neck Studies in 2021.
    Int J Radiat Oncol Biol Phys. 2022;113:243-251.
    PubMed    
    
    
    
93. CARDENAS CE, Blinde SE, Mohamed ASR, Ng SP, et al
    Comprehensive Quantitative Evaluation of Variability in Magnetic Resonance-Guided Delineation of Oropharyngeal Gross Tumor Volumes and High-Risk Clinical Target Volumes: An R-IDEAL Stage 0 Prospective Study.
    Int J Radiat Oncol Biol Phys. 2022;113:426-436.
    PubMed     Abstract available
    
    
    
94. SCHRODER C, Kothe A, De Angelis C, Basler L, et al
    NTCP Modeling for High-Grade Temporal Radionecroses in a Large Cohort of Patients Receiving Pencil Beam Scanning Proton Therapy for Skull Base and Head and Neck Tumors.
    Int J Radiat Oncol Biol Phys. 2022;113:448-455.
    PubMed     Abstract available
    
    
    May 2022
95. LIU X, Guo L, Xie FY, Hu WH, et al
    Necrosis in a Biomarker-driven, Phase 2 Trial of Adjuvant Apatinib in Patients of Nasopharyngeal Carcinoma with Residual Epstein-Barr Virus DNA after Radiotherapy.
    Int J Radiat Oncol Biol Phys. 2022 May 9. pii: S0360-3016(22)00410.
    PubMed     Abstract available
    
    
    
96. BUCKSTEIN MH, Anker CJ, Chuong MD, Hawkins MA, et al
    CROSSing into New Therapies for Esophageal Cancer.
    Int J Radiat Oncol Biol Phys. 2022;113:5-10.
    PubMed    
    
    
    
97. NG SP, Corry J, Ng WT
    The Janus Face in Defining the Optimal Radiation Dose for Nasopharyngeal Carcinoma.
    Int J Radiat Oncol Biol Phys. 2022;113:114-116.
    PubMed    
    
    
    
98. PAKKANEN P, Irjala H, Ilmarinen T, Halme E, et al
    Survival and Larynx Preservation in Early Glottic Cancer: A Randomized Trial Comparing Laser Surgery and Radiation Therapy.
    Int J Radiat Oncol Biol Phys. 2022;113:96-100.
    PubMed     Abstract available
    
    
    April 2022
99. WARD MC, Koyfman SA, Bakst RL, Margalit DN, et al
    Retreatment of Recurrent or Second Primary Head and Neck Cancer After Prior Radiation: Executive Summary of the American Radium Society(R) (ARS) Appropriate Use Criteria (AUC): Expert Panel on Radiation Oncology - Head and Neck Cancer.
    Int J Radiat Oncol Biol Phys. 2022 Apr 7. pii: S0360-3016(22)00280.
    PubMed     Abstract available
    
    
    
100. LU DJ, Luu M, Gay C, Nguyen AT, et al
     Nodal Metastasis Count and Oncologic Outcomes in Head and Neck Cancer: A Secondary Analysis of NRG/RTOG 9501, NRG/RTOG 0234, and EORTC 22931.
     Int J Radiat Oncol Biol Phys. 2022 Apr 5. pii: S0360-3016(22)00279.
     PubMed     Abstract available
     
     
     
101. LIAO W, He J, Luo X, Wu M, et al
     Automatic delineation of gross tumor volume based on magnetic resonance imaging by performing a novel semi-supervised learning framework in nasopharyngeal carcinoma.
     Int J Radiat Oncol Biol Phys. 2022 Apr 2. pii: S0360-3016(22)00277.
     PubMed     Abstract available
     
     
     
102. HE L, Pi Y, Li Y, Wu Y, et al
     Efficacy and safety of apatinib in radiation-induced brain injury among head and neck cancer: an open-label, single-arm, phase 2 study.
     Int J Radiat Oncol Biol Phys. 2022 Apr 1. pii: S0360-3016(22)00268.
     PubMed     Abstract available
     
     
     
103. QIU Y, Hu W, Wen M, Zhao W, et al
     Low Expression of ECT2 Confers Radiation Therapy Resistance Through Transcription Coupled Nucleolar DNA Damage Repair.
     Int J Radiat Oncol Biol Phys. 2022;112:1229-1242.
     PubMed     Abstract available
     
     
     March 2022
104. MCDOWELL L, Bossi P
     The Burning Question: Prophylactic Gabapentin for Mucositis-Related Pain in Patients Undergoing Chemoradiation Therapy for Head and Neck Cancer?
     Int J Radiat Oncol Biol Phys. 2022;112:938-941.
     PubMed    
     
     
     
105. HU K, Persky M
     Depth of Invasion in Oral Tongue Cancer and Risk of Regional Failure.
     Int J Radiat Oncol Biol Phys. 2022;112:851-852.
     PubMed    
     
     
     
106. KILIC SS, Campbell SR
     Don't Take the Bait, Radiate: Importance of Adjuvant Radiation Therapy for Oral Tongue Cancer.
     Int J Radiat Oncol Biol Phys. 2022;112:850.
     PubMed    
     
     
     
107. HARA JHL, Juloori A
     Node Out, About It? Consideration of Adjuvant Treatment of Oral Tongue Cancer.
     Int J Radiat Oncol Biol Phys. 2022;112:849.
     PubMed    
     
     
     
108. COOK A, Modh A, Ali H, Sheqwara J, et al
     Randomized Phase 3, Double-Blind, Placebo-Controlled Study of Prophylactic Gabapentin for the Reduction of Oral Mucositis Pain During the Treatment of Oropharyngeal Squamous Cell Carcinoma.
     Int J Radiat Oncol Biol Phys. 2022;112:926-937.
     PubMed     Abstract available
     
     
     
109. NI R, Zhou T, Ren G, Zhang Y, et al
     Deep learning-based automatic assessment of radiation dermatitis in nasopharyngeal carcinoma (NPC) patients.
     Int J Radiat Oncol Biol Phys. 2022 Mar 15. pii: S0360-3016(22)00244.
     PubMed     Abstract available
     
     
     
110. LI Y, Sakai M, Tsunoda A, Kubo N, et al
     Normal Tissue Complication Probability Model for Acute Radiation Dermatitis in Patients with Head and Neck Cancer Treated with Carbon Ion Radiotherapy.
     Int J Radiat Oncol Biol Phys. 2022 Mar 9. pii: S0360-3016(22)00195.
     PubMed     Abstract available
     
     
     
111. JOHUNG KL, Park HS
     Less Is More: Lower Doses for Intermediate-Term Oropharyngeal Control.
     Int J Radiat Oncol Biol Phys. 2022;112:585.
     PubMed    
     
     
     January 2022
112. FU S, Li Y, Han Y, Wang H, et al
     Diffusion-weighted MRI-guided dose painting in patients with locoregionally advanced nasopharyngeal carcinoma treated with induction chemotherapy plus concurrent chemoradiotherapy: a randomized, controlled clinical trial.
     Int J Radiat Oncol Biol Phys. 2022 Jan 21. pii: S0360-3016(22)00001.
     PubMed     Abstract available
     
     
     December 2021
113. BRENNAN MT, Treister NS, Sollecito TP, Schmidt BL, et al
     Tooth failure post-radiotherapy in head and neck cancer.
     Int J Radiat Oncol Biol Phys. 2021 Dec 5. pii: S0360-3016(21)03219.
     PubMed     Abstract available
     
     
     
114. YEOH KW, Yong FY
     Combined Modality Therapy in Extranodal NK/T Cell Lymphoma.
     Int J Radiat Oncol Biol Phys. 2021;111:1103-1105.
     PubMed    
     
     
     
115. THOMAS HR, Yom SS
     Right on the Nose: A Case of Locally Invasive Extranodal Lymphoma.
     Int J Radiat Oncol Biol Phys. 2021;111:1101-1102.
     PubMed    
     
     
     
116. CORRY J, Ng WT, Moore A, Choi HCW, et al
     Can Radiation Therapy Quality Assurance Improve Nasopharyngeal Cancer Outcomes in Low- and Middle-Income Countries: Reporting the First Phase of a Prospective International Atomic Energy Agency Study.
     Int J Radiat Oncol Biol Phys. 2021;111:1227-1236.
     PubMed     Abstract available
     
     
     
117. TOMASIK B, Papis-Ubych A, Stawiski K, Fijuth J, et al
     Serum MicroRNAs as Xerostomia Biomarkers in Patients With Oropharyngeal Cancer Undergoing Radiation Therapy.
     Int J Radiat Oncol Biol Phys. 2021;111:1237-1249.
     PubMed     Abstract available
     
     
     November 2021
118. RINGASH J
     Have We Tipped the Balance in HPV-Associated Oropharyngeal Cancer?: The Patient-Experience Side of the De-Escalation Balance Scale.
     Int J Radiat Oncol Biol Phys. 2021;111:887-889.
     PubMed    
     
     
     
119. CASSWELL G, Gough K, Drosdowsky A, Bressel M, et al
     Fear of Cancer Recurrence in Survivors of Human Papillomavirus-Associated Oropharyngeal Carcinoma.
     Int J Radiat Oncol Biol Phys. 2021;111:890-899.
     PubMed     Abstract available
     
     
     
120. LI X, Gao H, Zhu J, Huang Y, et al
     3D Deep Learning Model for the Pretreatment Evaluation of Treatment Response in Esophageal Carcinoma: A Prospective Study (ChiCTR2000039279).
     Int J Radiat Oncol Biol Phys. 2021;111:926-935.
     PubMed     Abstract available
     
     
     
121. RISCHIN D, King M, Kenny L, Porceddu S, et al
     Randomized Trial of Radiation Therapy With Weekly Cisplatin or Cetuximab in Low-Risk HPV-Associated Oropharyngeal Cancer (TROG 12.01) - A Trans-Tasman Radiation Oncology Group Study.
     Int J Radiat Oncol Biol Phys. 2021;111:876-886.
     PubMed     Abstract available
     
     
     
122. LI W, Xiao H, Li T, Ren G, et al
     Virtual Contrast-enhanced Magnetic Resonance Images Synthesis for Patients with Nasopharyngeal Carcinoma using Multimodality-guided Synergistic Neural Network.
     Int J Radiat Oncol Biol Phys. 2021 Nov 11. pii: S0360-3016(21)03115.
     PubMed     Abstract available
     
     
     
123. WANG Y, Thomas TV, Duggar WN, Roberts PR, et al
     Automatic Extracapsular Extension Identification in Head and Neck Cancer Using Deep Neural Network with Local-Global Information.
     Int J Radiat Oncol Biol Phys. 2021;111.
     PubMed     Abstract available
     
     
     
124. ZHU Z, Ho TY, Jin D, Yan K, et al
     Deep Learning Based Lymph Node Gross Tumor Volume Detection via Distance-Guided Gating Using CT and 18F-FDG PET in Esophageal Cancer Radiotherapy.
     Int J Radiat Oncol Biol Phys. 2021;111.
     PubMed     Abstract available
     
     
     
125. WANG Y, Nie S, Chen J, Wang C, et al
     Nomograms Predicting Response and Survival of Esophageal Squamous Cell Carcinoma Patients Treated With Anti-PD-1 Therapy.
     Int J Radiat Oncol Biol Phys. 2021;111.
     PubMed     Abstract available
     
     
     
126. WANG J, Wang J, Xiao LL, Wang S, et al
     Addition of Induction or Consolidation Chemotherapy in Definitive Concurrent Chemoradiotherapy vs. Concurrent Chemoradiotherapy Alone for Patients With Unresectable Esophageal Cancer: A Systematic Review and Meta-Analysis.
     Int J Radiat Oncol Biol Phys. 2021;111.
     PubMed     Abstract available
     
     
     
127. PETERS GW, Wang S, Peters NV, Dhanasopan A, et al
     Pre-Operative Chemoradiotherapy With or Without Induction Chemotherapy for Operable Locally-Advanced Esophageal Cancer.
     Int J Radiat Oncol Biol Phys. 2021;111.
     PubMed     Abstract available
     
     
     
128. MORSE R, Mouw T, Moreno M, Dipasco P, et al
     Comparison of Postoperative Esophagectomy Outcomes in Esophageal Cancer Patients Receiving Preoperative Radiotherapy at an Academic Medical Center vs. Community Medical Centers.
     Int J Radiat Oncol Biol Phys. 2021;111.
     PubMed     Abstract available
     
     
     
129. MIYAZAKI T, Myojin M, Takahashi H, Hosokawa M, et al
     The Role of Endoscopic Resection in Long-Term Results of Chemoradiotherapy for T1bN0M0 Thoracic Esophageal Squamous Cell Carcinoma.
     Int J Radiat Oncol Biol Phys. 2021;111.
     PubMed     Abstract available
     
     
     
130. POKHREL D, Bernard ME, Lockhart D, Jeremiah J, et al
     HyperArc VMAT SRT for Locally Recurrent Previously-Irradiated Head and Neck Cancers: Plan Quality, Treatment Delivery Accuracy and Efficiency.
     Int J Radiat Oncol Biol Phys. 2021;111.
     PubMed     Abstract available
     
     
     
131. LYU B, Yin Y, Shi M, Zhao L, et al
     Long-Term Clinical Outcome and Safety Analysis of Superficial Esophageal Cancer Patients Receiving Definite or Adjuvant/Salvage Radiotherapy.
     Int J Radiat Oncol Biol Phys. 2021;111.
     PubMed     Abstract available
     
     
     
132. LIU J, Zeng X, Zhou X, Xu Y, et al
     Factors Associated with Pathologic Complete Response After Neoadjuvant Chemoradiotherapy for Esophageal Cancer.
     Int J Radiat Oncol Biol Phys. 2021;111.
     PubMed     Abstract available
     
     
     
133. LIN ZY, Cai WJ, Chen YY, Gao BZ, et al
     Survival Prediction of Esophageal Cancer Using 3D Residual Autoencoder and Proportional Hazards Model.
     Int J Radiat Oncol Biol Phys. 2021;111.
     PubMed     Abstract available
     
     
     
134. AUTREY CM, Mittauer KE, Alvarez D, Chuong MD, et al
     MR-Guided Radiotherapy (MRgRT) for Laryngeal Cancer With Real-Time Visualization of Intrafraction Larynx Motion.
     Int J Radiat Oncol Biol Phys. 2021;111.
     PubMed     Abstract available
     
     
     
135. SZEWCZYK C, Liao Y, Al-Khudari S, Jelinek M, et al
     A Novel Immobilization Method Using 3D Printing for the Treatment of Head and Neck Cancer.
     Int J Radiat Oncol Biol Phys. 2021;111.
     PubMed     Abstract available
     
     
     
136. WU RY, Gao L, Huang X, Xiao J, et al
     Stereotactic Body Radiation Therapy for the First-Line Comprehensive Treatment of Oligometastatic Nasopharyngeal Carcinoma: A Prospective, Single-Arm, Phase II Trial.
     Int J Radiat Oncol Biol Phys. 2021;111.
     PubMed     Abstract available
     
     
     
137. HO YC, Lai YC, Lin HY, Lin JB, et al
     The Volume of Low-Dose Thoracic Irradiation Influences Systemic Inflammation-Immunity Status After Chemoradiation in Esophageal Cancer.
     Int J Radiat Oncol Biol Phys. 2021;111.
     PubMed     Abstract available
     
     
     
138. JAWORSKI E, Sun Y, Schonewolf C, Gharzai LA, et al
     Local Control With Cemiplimab Monotherapy for Unresectable Locally Advanced Cutaneous Squamous Cell Carcinoma of the Head and Neck.
     Int J Radiat Oncol Biol Phys. 2021;111.
     PubMed     Abstract available
     
     
     
139. YANG GQ, Echevarria M, Caudell JJ
     Stereotactic Body Radiation Therapy (SBRT) With or Without Daily Systemic Therapy for Re-Irradiation of Unresectable, Recurrent, Head and Neck Squamous Cell Carcinoma.
     Int J Radiat Oncol Biol Phys. 2021;111.
     PubMed     Abstract available
     
     
     
140. CANAVAN JF, Campbell SR, Koyfman S, Woody NM, et al
     Second Primary Head and Neck Malignancies in Patients With Prior Human Papilloma Virus (HPV) Associated Oropharyngeal Squamous Cell Carcinoma (OPSCC) Treated With Radiation.
     Int J Radiat Oncol Biol Phys. 2021;111.
     PubMed     Abstract available
     
     
     
141. DOHOPOLSKI M, Wang K, Morgan HE, Chen L, et al
     Predicting Feeding Tube Placement in Head and Neck Cancer Patients Receiving Radiation Therapy With Machine Learning.
     Int J Radiat Oncol Biol Phys. 2021;111.
     PubMed     Abstract available
     
     
     
142. IYER A, Steber C, Porosnicu M, Lycan T, et al
     Short-Course Palliative Radiotherapy Combined With Immunotherapy for Recurrent/Advanced/Metastatic Head and Neck Cancer.
     Int J Radiat Oncol Biol Phys. 2021;111.
     PubMed     Abstract available
     
     
     
143. VEALE C, Boggs H, Liu Y, McDonald AM, et al
     Predictors of Ability to Complete Prescribed Concurrent Cisplatin Chemotherapy Regimen and Effect on Outcomes in Oropharyngeal Head and Neck Cancer Patients Treated With Radiotherapy.
     Int J Radiat Oncol Biol Phys. 2021;111.
     PubMed     Abstract available
     
     
     
144. KUTUK T, McAllister N, Rzepczynski AE, Young G, et al
     Submandibular Gland Transfer for the Prevention of Radiation Induced Xerostomia in Head and Neck Cancer - Dosimetric Impact With Intensity Modulated Radiotherapy.
     Int J Radiat Oncol Biol Phys. 2021;111.
     PubMed     Abstract available
     
     
     
145. MAXWELL RJL, Poirier K, Montone K, Swisher-McClure SD, et al
     Detection of Plasma Circulating Tumor-Tissue Modified HPV DNA Following Trans-Oral Robotic Surgery (TORS) and Neck Dissection for p16+ Oropharyngeal Squamous Cell Carcinoma.
     Int J Radiat Oncol Biol Phys. 2021;111.
     PubMed     Abstract available
     
     
     
146. SHER DJ, Avkshtol V, Moon D, Wang J, et al
     Recurrence and Quality-of-Life Following Involved Node Radiotherapy for Head and Neck Squamous Cell Carcinoma: Initial Results From the Phase II INRT-Air Trial.
     Int J Radiat Oncol Biol Phys. 2021;111.
     PubMed     Abstract available
     
     
     
147. LU DJ, Luu M, Gay C, Nguyen AT, et al
     Association of Pathologic Nodal Metastasis Count With Oncologic Outcomes in Head and Neck Cancer: A Secondary Analysis of RTOG 9501, RTOG 0234, and EORTC 22931.
     Int J Radiat Oncol Biol Phys. 2021;111.
     PubMed     Abstract available
     
     
     
148. SAHA S, Mallick I, Chatterjee S
     Adjuvant Radiation Therapy Nodal Target Volumes in Oral Cancer: Do Consensus Guidelines Reflect Patterns of Failure?
     Int J Radiat Oncol Biol Phys. 2021;111.
     PubMed     Abstract available
     
     
     
149. LOESER A, Abel J, Kutz LM, Krause L, et al
     Head and Neck Cancer Patients Under (Chemo-) Radiotherapy Undergoing NUTritional Intervention: Results From the Prospective Randomized HEADNUT-Trial.
     Int J Radiat Oncol Biol Phys. 2021;111.
     PubMed     Abstract available
     
     
     
150. LOKESH V, Ashalatha D, Naveen T, Vijay C, et al
     Effect of Bio Adhesive Barrier-Forming Oral Liquid on Oral Mucositis Severity and Duration in a Clinical Setting With Concurrent Chemo-Radiation for Patients With Head and Neck Cancer.
     Int J Radiat Oncol Biol Phys. 2021;111.
     PubMed     Abstract available
     
     
     
151. GEORGE J, Vaughn J, Hobson M, Mittauer KE, et al
     ITV-Negation and Dose Fall-Off Features Result in OAR Dosimetric Superiority Favoring MR-Guided Radiotherapy (MRgRT), and Intensity Modulated Proton Therapy (IMPT) Over Volumetric Modulated Arc Therapy (VMAT) for Treatment of Distal Esophageal Cancer.
     Int J Radiat Oncol Biol Phys. 2021;111.
     PubMed     Abstract available
     
     
     
152. ZIYAN Z, Shen M, Jixi L, Kang L, et al
     Genome-Scale CRISPR-Cas9 Knockout Screening in Nasopharyngeal Carcinoma for Radiosensitive and Radioresistant Genes.
     Int J Radiat Oncol Biol Phys. 2021;111.
     PubMed     Abstract available
     
     
     
153. YANG Y, Patel SH, Bridhikitti J, Wong WW, et al
     Seed Spots Analysis to Characterize Linear Energy Transfer (LET) Effect in the Adverse Event Regions of Head and Neck Cancer Patients Treated by Intensity Modulated Proton Therapy (IMPT).
     Int J Radiat Oncol Biol Phys. 2021;111.
     PubMed     Abstract available
     
     
     
154. ZHOU F, Wang J, Shayan G, Huang X, et al
     Prognostic Significance of Tumor Infiltrating Lymphocytes (TILs) and Programmed Cell Death-Ligand 1 (PD-L1) in Nasopharyngeal Carcinoma.
     Int J Radiat Oncol Biol Phys. 2021;111.
     PubMed     Abstract available
     
     
     
155. LIU X, Wu B, Huang J, Ding Q, et al
     Patterns of Local-Regional Relapse Following Intensity-Modulated Radiotherapy for Patients With Nasopharyngeal Carcinoma.
     Int J Radiat Oncol Biol Phys. 2021;111.
     PubMed     Abstract available
     
     
     
156. PENG X, Liu H, Yin Q, Lang J, et al
     Predictive Value of Ki-67 for Neoadjuvant Chemotherapy in Locally Advanced Nasopharyngeal Carcinoma.
     Int J Radiat Oncol Biol Phys. 2021;111.
     PubMed     Abstract available
     
     
     
157. LU Y, Huang H
     Maintenance Intervention Improves Survival in Patients With Metastatic Nasopharyngeal Carcinoma Who Benefit From First-Line Treatment: A Prospective Multicenter Randomized Controlled Clinical Study.
     Int J Radiat Oncol Biol Phys. 2021;111.
     PubMed     Abstract available
     
     
     
158. MILLER JA, Huang C, Sahoo MK, Wang H, et al
     Comparison of Multiplex Real-Time PCR and Droplet Digital PCR for Detection of Plasma Epstein-Barr Virus DNA in Nasopharyngeal Carcinoma.
     Int J Radiat Oncol Biol Phys. 2021;111.
     PubMed     Abstract available
     
     
     
159. MILLER JA, Sahoo MK, Huang C, Wang H, et al
     Multiplex Epstein-Barr Virus Genotyping PCR Detects High-Risk Variants in Plasma for Population-Level Nasopharyngeal Carcinoma Screening.
     Int J Radiat Oncol Biol Phys. 2021;111.
     PubMed     Abstract available
     
     
     
160. LI Y, Liu Q, Zhu Y, Zang J, et al
     Induction Chemotherapy Followed by Concurrent Chemoradiotherapy vs. Concurrent Chemoradiotherapy in T4N0-1M0 Patients With Nasopharyngeal Carcinoma: A Multicenter Retrospective Study.
     Int J Radiat Oncol Biol Phys. 2021;111.
     PubMed     Abstract available
     
     
     
161. SU H, Jin F, Li Y, Wu W, et al
     Comparative Analysis of Clinical Results of Compared With TPF Induction of Chemotherapy and PF Adjuvant Chemotherapy Combined With Cisplatin Radiochemotherapy for Locally Advanced Nasopharyngeal Carcinoma.
     Int J Radiat Oncol Biol Phys. 2021;111.
     PubMed     Abstract available
     
     
     
162. JACINTO JKM, Huang SH, Su J, Kim J, et al
     Clinical Behavior and Outcome of HPV-Positive Nasopharyngeal Carcinoma.
     Int J Radiat Oncol Biol Phys. 2021;111.
     PubMed     Abstract available
     
     
     
163. XU H, Lu L, Lu T, Xu Y, et al
     Identifying the Optimal Candidates for the Best Utilization of Locoregional Radiation Therapy in Patients With De Novo Metastatic Nasopharyngeal Carcinoma.
     Int J Radiat Oncol Biol Phys. 2021;111.
     PubMed     Abstract available
     
     
     
164. GUO Q, Xiao N, Xu H, Zong J, et al
     Evaluating the Rationality of the International Guideline's Recommendations Regarding Selective Coverage of Level Ib in Node Clinical Target Volume With Nasopharyngeal Carcinoma: Results From a Real-World Series.
     Int J Radiat Oncol Biol Phys. 2021;111.
     PubMed     Abstract available
     
     
     
165. FENG M, Yin Q, Qi YX, Lu L, et al
     Low-Dose Ultra-Fractionated Radiotherapy as a Chemosensitizer of Neoadjuvant Chemotherapy for Locally Advanced Nasopharyngeal Carcinoma: A Preliminary Results of the Phase II Trial.
     Int J Radiat Oncol Biol Phys. 2021;111.
     PubMed     Abstract available
     
     
     
166. CHOW JCH, Kitpanit S, Lee A, Bao K, et al
     Cranial Neuropathies in Advanced Nasopharyngeal Carcinoma: Neurological Recovery and Prognosis After Modern Radiotherapy and Systemic Chemotherapy.
     Int J Radiat Oncol Biol Phys. 2021;111.
     PubMed     Abstract available
     
     
     
167. CHUA MLK, Sim AYL, Ong EHW, Huang L, et al
     An Immune-Based Genomic Classifier (GC) Prognosticates for Survival in Endemic Nasopharyngeal Carcinoma.
     Int J Radiat Oncol Biol Phys. 2021;111.
     PubMed     Abstract available
     
     
     
168. CHENG WJ, Wan SL, Zhaodong F, Zhou Q, et al
     Automatic Gross Tumor Volume Delineation of Nasopharyngeal Carcinoma in 3D CT Images.
     Int J Radiat Oncol Biol Phys. 2021;111.
     PubMed     Abstract available
     
     
     
169. FARRIS JC, Steber C, Chan MD, Cramer CK, et al
     IMRT With Planned Gamma Knife Radiosurgery Boost for Head and Neck Cancer With Extensive Disease in Proximity to Critical Structures.
     Int J Radiat Oncol Biol Phys. 2021;111.
     PubMed     Abstract available
     
     
     
170. VALLE L, Chu FI, Erman A, Hernandez J, et al
     Patient-Reported Quality of Life Outcomes After Integrating Exclusive Liquid Meal Replacement in Patients With Head and Neck Cancer Undergoing Chemoradiation: Results From a Phase II Study.
     Int J Radiat Oncol Biol Phys. 2021;111.
     PubMed     Abstract available
     
     
     
171. RUHLE A, Stromberger C, Haehl E, Senger C, et al
     Development and External Validation of a Prognostic Classifier for Elderly Head-and-Neck Cancer Patients Undergoing (Chemo)radiation.
     Int J Radiat Oncol Biol Phys. 2021;111.
     PubMed     Abstract available
     
     
     
172. STEBER C, Russell G, Rush MC, Shenker RF, et al
     Impact of Treatment Timing on Disease Outcomes in Patients Treated With Definitive Concurrent Chemoradiation for Head and Neck Cancer.
     Int J Radiat Oncol Biol Phys. 2021;111.
     PubMed     Abstract available
     
     
     
173. AULAKH SS, Dyer BA, Rao SSD
     Evaluation of Risk Factors for Developing Hypothyroidism Following Radiation Therapy for Head and Neck Cancers.
     Int J Radiat Oncol Biol Phys. 2021;111.
     PubMed     Abstract available
     
     
     
174. O'KEEFE R, LaRiviere MJ, Vachani C, Hampshire MK, et al
     Contribution of Family History of Head and Neck Cancer and Associated Risk Factors: Analysis of an Internet Based Risk Assessment Tool.
     Int J Radiat Oncol Biol Phys. 2021;111.
     PubMed     Abstract available
     
     
     
175. NG SP, Martin GV, Guha-Thakurta N, Wang H, et al
     Patterns of Failure After IMRT and Proton Re-Irradiation for Patients With Recurrent Head and Neck Cancer.
     Int J Radiat Oncol Biol Phys. 2021;111.
     PubMed     Abstract available
     
     
     
176. LENZIE A, Hoyle J, Yang ES, Spencer SA, et al
     Pain, Weight Loss, and Quality of Life in a Supportive Care Trial for Patients With Advanced Head and Neck Cancer.
     Int J Radiat Oncol Biol Phys. 2021;111.
     PubMed     Abstract available
     
     
     
177. MORENO AC, Wang XA, Mohamed AS, Wang H, et al
     Patterns of Failure After SBRT Reirradiation for Recurrent Head and Neck Cancer.
     Int J Radiat Oncol Biol Phys. 2021;111.
     PubMed     Abstract available
     
     
     
178. KUT C, McNutt TR, Lee J, Sheikh K, et al
     Spatial Dose Sparing for Organs-at-Risk (OARs) to Decrease Severe Lymphopenia Risks in Head and Neck Cancer.
     Int J Radiat Oncol Biol Phys. 2021;111.
     PubMed     Abstract available
     
     
     
179. LEE J, Lee JJB, Lee CG Jr
     Outcome of Dental Extraction and Implants in Irradiated Head and Neck Cancer Patients.
     Int J Radiat Oncol Biol Phys. 2021;111.
     PubMed     Abstract available
     
     
     
180. KRC RF, Singh S, Weir JS
     Photobiomodulation Laser Therapy During Chemoradiation for Head and Neck Cancer: Effect on Mucositis, Weight Loss, and Feeding Tube Dependence.
     Int J Radiat Oncol Biol Phys. 2021;111.
     PubMed     Abstract available
     
     
     
181. KIM M, Narinesingh D, Hamm J, Marwaha A, et al
     Radiation Therapy in Elderly Patients With Squamous Cell Carcinoma of the Head and Neck - Insights From Real World Registry DATA (2007-2017).
     Int J Radiat Oncol Biol Phys. 2021;111.
     PubMed     Abstract available
     
     
     
182. JAWORSKI E, Sun Y, Vineberg KA, Mierzwa ML, et al
     Dosimetric Analysis for Predicting Secondary Lymphedema After Radiation for Head and Neck Cancer.
     Int J Radiat Oncol Biol Phys. 2021;111.
     PubMed     Abstract available
     
     
     
183. KIM K, Doucette A, Amaniera I, Baumann BC, et al
     Acute Toxicity in Patients Treated With Proton vs. Photon Chemoradiotherapy for Locally Advanced Head and Neck Cancer.
     Int J Radiat Oncol Biol Phys. 2021;111.
     PubMed     Abstract available
     
     
     
184. HUSAIN ZA, Chen H, Biswas T, Dagan R, et al
     Outcomes for Oligometastatic Head and Neck Cancer Undergoing SBRT: Results From an International Multi-Institutional Consortium.
     Int J Radiat Oncol Biol Phys. 2021;111.
     PubMed     Abstract available
     
     
     
185. ECHEVARRIA M, Chung C, Kirtane K, Kish JA, et al
     Outcomes of Phase I Trial of Patients With Recurrent Head and Neck Squamous Cell Carcinoma Treated With Re-Irradiation With Stereotactic Body Radiation Therapy and Concurrent Cisplatin.
     Int J Radiat Oncol Biol Phys. 2021;111.
     PubMed     Abstract available
     
     
     
186. DHAKAL A, Mladkova N, Blakaj DM
     Divergent Role of Intermediate Filaments in Clinical Outcomes of HPV-Positive and HPV-Negative Head and Neck Squamous Cell Carcinoma.
     Int J Radiat Oncol Biol Phys. 2021;111.
     PubMed     Abstract available
     
     
     
187. DOOLEY S, Tobillo R, de Joya E, Freedman LM, et al
     Destructive-Type TP53 Mutations are Independently Associated With Worse Overall Survival in Patients With HPV-Negative Head and Neck Squamous Cell Carcinoma.
     Int J Radiat Oncol Biol Phys. 2021;111.
     PubMed     Abstract available
     
     
     
188. SCHLAFSTEIN A, Goyal S, Amini A, Karam SD, et al
     Does Operability Status Influence Outcomes in Patients With T4 Larynx Cancer Undergoing Larynx Preservation?
     Int J Radiat Oncol Biol Phys. 2021;111.
     PubMed     Abstract available
     
     
     
189. OTSUKA M, Yasuda K, Minatogawa H, Fujita Y, et al
     A Dosimetric Analysis of Locoregional Failure Using Deformable Image Registration in Hypopharyngeal Cancer After Sequential-Boost Intensity-Modulated Radiotherapy.
     Int J Radiat Oncol Biol Phys. 2021;111.
     PubMed     Abstract available
     
     
     
190. LUO X, Yi J, Wang J, Wu R, et al
     Hypopharyngeal Carcinoma With Synchronous and Metachronous Multiple Malignancies: Clinical Characteristics and Prognosis Analysis of 673 Real World Cases.
     Int J Radiat Oncol Biol Phys. 2021;111.
     PubMed     Abstract available
     
     
     
191. GONG H, Zhang T, Li M, Peng S, et al
     Radical Surgery vs. Definitive Concurrent Chemoradiotherapy for Locally Advanced Hypopharyngeal Cancer.
     Int J Radiat Oncol Biol Phys. 2021;111.
     PubMed     Abstract available
     
     
     
192. LUO X, Yi J, Wu R, Huang X, et al
     Response-Adapted Strategy Based on Early Response to Radiotherapy Achieves Favorable Survival With Functional Larynx in Resectable, Locally Advanced Hypopharyngeal Cancer: An Analysis of 423 Real-World Cases.
     Int J Radiat Oncol Biol Phys. 2021;111.
     PubMed     Abstract available
     
     
     
193. ANDERSON E, Luu M, Lu DJ, Chung EM, et al
     Predicting Pathologic Lymph Node Positivity in cN0 Pharynx and Larynx Cancers in the Modern Imaging Era.
     Int J Radiat Oncol Biol Phys. 2021;111.
     PubMed     Abstract available
     
     
     
194. FRANKART AJ, Sadraei NH, Huth B, Redmond KP, et al
     Concurrent Immunotherapy With Chemoradiation for Definitive Management of Locally Advanced Laryngeal Cancer: A Prospective Trial.
     Int J Radiat Oncol Biol Phys. 2021;111.
     PubMed     Abstract available
     
     
     
195. SABA NF, Wong S, Stokes WA, Rupji M, et al
     CA209-9KY: Phase II Study of IMRT Re-Irradiation and Concurrent/Adjuvant Nivolumab (Nivo) in Patients With Loco Regionally Recurrent or Second Primary Head and Neck Squamous Cell Carcinoma (HNSCC) - Toxicity and Quality of Life (QoL) Results.
     Int J Radiat Oncol Biol Phys. 2021;111.
     PubMed     Abstract available
     
     
     
196. SHI Z, Zhu X, Ke S, Qiu H, et al
     Clinical Parameters Predicting Prognosis for Elderly Patients With Synchronous Oligometastatic Esophageal Squamous Cell Carcinoma.
     Int J Radiat Oncol Biol Phys. 2021;111.
     PubMed     Abstract available
     
     
     
197. MLADKOVA N, Blakaj DM, Raval R
     Patterns of Care for Incarcerated Head and Neck Cancer Patient Receiving Radiation: A Single-Center Retrospective Descriptive Cohort Study.
     Int J Radiat Oncol Biol Phys. 2021;111.
     PubMed     Abstract available
     
     
     
198. CHANG X, Zhang W, Yang J, Yu S, et al
     Recurrence Risk Stratification Based on Competing-Risks Nomograms to Identify Patients With Esophageal Cancer Who May Benefit From Postoperative Radiotherapy.
     Int J Radiat Oncol Biol Phys. 2021;111.
     PubMed     Abstract available
     
     
     
199. SUMNER W, Ray X, Sutton L, Rebibo D, et al
     Genetic Alterations as Predictors of Radiation-Induced Toxicity in Head and Neck Squamous Cell Carcinoma.
     Int J Radiat Oncol Biol Phys. 2021;111.
     PubMed     Abstract available
     
     
     
200. WANG L, Cao JZ, Wang X, Li Y, et al
     The Molecular Effects of a PARP-1/-2 Inhibitor on Proton and Photon Radiotherapy in Head and Neck Cancer Cells.
     Int J Radiat Oncol Biol Phys. 2021;111.
     PubMed     Abstract available
     
     
     
201. ZHAO C, Meng X, Jin F, Li Y, et al
     We Hypothesize That BMAL1 Has a Positive Regulatory Effect on the Radiosensitivity of Nasopharyngeal Carcinoma.
     Int J Radiat Oncol Biol Phys. 2021;111.
     PubMed     Abstract available
     
     
     
202. DONG J, Wen B, Wang C, Zhang T, et al
     Application of Hypoxia-Driven Dual-Reporter Model to Explore the Effect of Hypoxia on Radiosensitivity of Human Nasopharyngeal Carcinoma Cells.
     Int J Radiat Oncol Biol Phys. 2021;111.
     PubMed     Abstract available
     
     
     
203. ROVEDA J, Murdaugh DL, McConathy JE, Milner D, et al
     Brain Glucose Metabolism is Reduced After Radiation Therapy for Head and Neck Cancer.
     Int J Radiat Oncol Biol Phys. 2021;111.
     PubMed     Abstract available
     
     
     
204. TOBILLO R, de Joya E, Dooley S, Freedman LM, et al
     Female Sex and Increased Immune Marker mRNA Gene Expression are Associated With Decreased Overall Survival in Patients With HPV-Negative Head and Neck Cancer.
     Int J Radiat Oncol Biol Phys. 2021;111.
     PubMed     Abstract available
     
     
     
205. WANG Y, Li T, Lv J, Xiao L, et al
     Mechanism of Increased Treg Frequency Induced by Irradiated Esophageal Squamous Cell Carcinoma.
     Int J Radiat Oncol Biol Phys. 2021;111.
     PubMed     Abstract available
     
     
     
206. JIN F, Chen Y, Jiang Z, Li Y, et al
     The Correlation Study of Circadian Clock Gene BMAL1 Regulates the Biological Behavior of Human Nasopharyngeal Carcinoma Cell After Radiotherapy.
     Int J Radiat Oncol Biol Phys. 2021;111.
     PubMed     Abstract available
     
     
     
207. HOYLE J, Lenzie A, Kenzik K, Ward K, et al
     Patient Factors Associated With Loss to Radiation Oncology Specialty Follow-Up Among Head and Neck Cancer Survivors.
     Int J Radiat Oncol Biol Phys. 2021;111.
     PubMed     Abstract available
     
     
     
208. MAYO ZS, Ilori E, Fleming CW, Woody NM, et al
     Limited Toxicity of Hypofractionated Intensity Modulated Radiation Therapy (H-IMRT) for Head and Neck Cancer.
     Int J Radiat Oncol Biol Phys. 2021;111.
     PubMed     Abstract available
     
     
     
209. COKE A, Gilbert M, Hill S, Siddiqui F, et al
     A Multidisciplinary Approach to the Reactive Placement of Nasogastric Feeding Tubes in Clinic During Treatment for Head and Neck Cancer.
     Int J Radiat Oncol Biol Phys. 2021;111.
     PubMed     Abstract available
     
     
     
210. DING S, Liu H, Wang B, Li Y, et al
     Assessment of Dose Accuracy for MR-Guided Online Adaptive Radiotherapy for Nasopharyngeal Carcinoma.
     Int J Radiat Oncol Biol Phys. 2021;111.
     PubMed     Abstract available
     
     
     
211. ZAHID MU, Caudell JJ, Moros EG, Mohamed AS, et al
     In Silico Trial to Estimate Personalized RT Dose in Head and Neck Cancer.
     Int J Radiat Oncol Biol Phys. 2021;111.
     PubMed     Abstract available
     
     
     
212. OLSSON CE, Raunert I, Pauli N, Tuomi L, et al
     Feasibility of Mastication-Structure-Sparing Radiotherapy for Head and Neck Cancer.
     Int J Radiat Oncol Biol Phys. 2021;111.
     PubMed     Abstract available
     
     
     
213. ABUSAIF A, Moawad A, van Dijk LV, Fuentes D, et al
     Radiomic Correlates of Mandibular Osteoradionecrosis After Radiation Treatment of Head and Neck Cancer Patients.
     Int J Radiat Oncol Biol Phys. 2021;111.
     PubMed     Abstract available
     
     
     
214. GUPTA H, Deek MP, McNutt TR, Lee J, et al
     Predicting Progression-Free Survival Using Primary and Nodal Radiomic Features in Head and Neck Cancer.
     Int J Radiat Oncol Biol Phys. 2021;111.
     PubMed     Abstract available
     
     
     
215. CHEN Q, Bernard ME, Duan J, Feng X, et al
     A Transfer Learning Approach for Improving OAR Segmentation in the Adaptive Therapy or Retreatment of Head and Neck Cancer.
     Int J Radiat Oncol Biol Phys. 2021;111.
     PubMed     Abstract available
     
     
     
216. DING M, Cui H, Li B, Zou B, et al
     Integrating Preoperative CT and Clinical Factors for Lymph Node Metastasis Prediction in Esophageal Cancer by Feature-Wise Attentional Graph Neural Network (FAGNN).
     Int J Radiat Oncol Biol Phys. 2021;111.
     PubMed     Abstract available
     
     
     
217. MORGAN HE, Wang K, Dohopolski M, Liang X, et al
     Explainable Boosting Machine Model with a Parallel Ensemble Design Predicts Local Failure for Head and Neck Cancer With Clinical, CT, and Delta CBCT Radiomic Features.
     Int J Radiat Oncol Biol Phys. 2021;111.
     PubMed     Abstract available
     
     
     
218. PIFER P, Kumar M, Yang L, Xie T, et al
     Focal Adhesion Kinase Drives Resistance to Therapy in HPV-Negative Head and Neck Squamous Cell Carcinoma in a p53-Dependent Manner.
     Int J Radiat Oncol Biol Phys. 2021;111.
     PubMed     Abstract available
     
     
     
219. MAYO C, Mierzwa ML, Medlin R, Casper K, et al
     Anticipating Poor Outcomes: A Prognostic Machine Learning Model of Unplanned Visits to the Emergency Department for Patients Undergoing Treatment for Head and Neck Cancer Using Comprehensive Multi-Factor Electronic Health Records.
     Int J Radiat Oncol Biol Phys. 2021;111.
     PubMed     Abstract available
     
     
     
220. LIU F, Fu SN, Chen YZ, Yan OY, et al
     A Randomized Controlled Trial of Reirradiation Using Diffusion-Weighted MRI Guided Dose-Painting vs. CT-Based Radiotherapy for Locally Recurrent T3 to T4 Nasopharyngeal Carcinoma.
     Int J Radiat Oncol Biol Phys. 2021;111.
     PubMed     Abstract available
     
     
     
221. NICOLAY NH, Ruhle A, Mix M, Wiedenmann N, et al
     Development of a Hypoxia-Immune Prognostic Classifier for Head-and-Neck Cancer Patients Undergoing Radiotherapy - Results From a Prospective Imaging Trial.
     Int J Radiat Oncol Biol Phys. 2021;111.
     PubMed     Abstract available
     
     
     
222. MIERZWA ML, Lee C, Schipper M, Aryal MP, et al
     Randomized Phase II Study of DCE-MRI-Based Dose Escalation for Poor-Prognosis Head and Neck Cancer.
     Int J Radiat Oncol Biol Phys. 2021;111.
     PubMed     Abstract available
     
     
     
223. LEE YS, Bradley ST, Gurel Z, Nickel KP, et al
     Mitophagy Induction by ROS-PINK1 Signaling Protects Head and Neck Cancer From Radiotherapy.
     Int J Radiat Oncol Biol Phys. 2021;111.
     PubMed     Abstract available
     
     
     
224. POLAN D, Mierzwa ML, Epelman M, Sun Y, et al
     Prioritized Optimization of Total Toxicity Burden for Head and Neck Cancer Patients.
     Int J Radiat Oncol Biol Phys. 2021;111.
     PubMed     Abstract available
     
     
     
225. CREHANGE G, M'vondo C, Bertaut A, Pereira R, et al
     Exclusive Chemoradiotherapy With or Without Radiation Dose Escalation in Esophageal Cancer: Multicenter Phase 2/3 Randomized Trial CONCORDE (PRODIGE-26).
     Int J Radiat Oncol Biol Phys. 2021;111.
     PubMed     Abstract available
     
     
     
226. FENG M, Yan L, Du X, Wang H, et al
     Early Efficacy Prediction of Nasopharyngeal Carcinoma Based on 3D-ADC Acquired During Radiotherapy: A Phase II Prospective Study.
     Int J Radiat Oncol Biol Phys. 2021;111.
     PubMed     Abstract available
     
     
     
227. BRIZEL DM, Mowery YM, Zhen W, Chan J, et al
     A Phase 1-2 Trial of Concurrent Radiation Therapy, Cisplatin and BMX-001 in Locally Advanced Head and Neck Cancer.
     Int J Radiat Oncol Biol Phys. 2021;111.
     PubMed     Abstract available
     
     
     
228. QIAN DC, Ulrich BC, Peng G, Zhao H, et al
     Outcomes Stratification of Head and Neck Cancer Using Pre- and Post-Treatment DNA Methylation in Peripheral Blood.
     Int J Radiat Oncol Biol Phys. 2021;111.
     PubMed     Abstract available
     
     
     
229. XIANG L, Wu J
     Five-Year Result After Reduction of the Target Volume of Intensity Modulated Radiotherapy Following Induction Chemotherapy in Locoregionally Advanced Nasopharyngeal Carcinoma: A Phase 3, Multicenter, Randomized Controlled Trial.
     Int J Radiat Oncol Biol Phys. 2021;111.
     PubMed     Abstract available
     
     
     
230. LIU F, Fu SN, Yan OY, Chen YZ, et al
     A Randomized Controlled Trial of Cognitive Behavior Therapy for Reducing Anxiety and Depressive Symptoms in Patients With Locally Recurrent Nasopharyngeal Carcinoma Receiving Reirradiation.
     Int J Radiat Oncol Biol Phys. 2021;111.
     PubMed     Abstract available
     
     
     
231. CAI G, Yu J, Meng X
     Dosimetric Predictors of Cardiac Events After Concurrent Chemoradiotherapy for Locally Advanced Esophageal Cancer.
     Int J Radiat Oncol Biol Phys. 2021;111.
     PubMed     Abstract available
     
     
     October 2021
232. RABEN D, Raben A
     A Two-Headed Heated Debate.
     Int J Radiat Oncol Biol Phys. 2021;111:310.
     PubMed    
     
     
     
233. SIT D, Koh WX, Shokoohi A, Raycraft T, et al
     External Beam Radiation Therapy in pT4 Well-Differentiated Thyroid Cancer: A Population-Based Study of 405 Patients.
     Int J Radiat Oncol Biol Phys. 2021;111:468-478.
     PubMed     Abstract available
     
     
     
234. LI Y, Liu H, Sun C, Yin X, et al
     Comparison of Clinical Efficacy of Neoadjuvant Chemoradiation Therapy Between Lower and Higher Radiation Doses for Carcinoma of the Esophagus and Gastroesophageal Junction: A Systematic Review.
     Int J Radiat Oncol Biol Phys. 2021;111:405-416.
     PubMed     Abstract available
     
     
     September 2021
235. STEENBAKKERS RJHM, van Rijn-Dekker MI, Stokman MA, Kierkels RGJ, et al
     Parotid gland stem cell sparing radiotherapy for head and neck cancer patients: a double-blind randomized controlled trial.
     Int J Radiat Oncol Biol Phys. 2021 Sep 23. pii: S0360-3016(21)02827.
     PubMed     Abstract available
     
     
     
236. VISSER S, den Otter LA, Ribeiro CO, Korevaar EW, et al
     Diaphragm Based Position Verification to Improve Daily Target Dose Coverage in Proton and Photon Radiotherapy Treatment of Distal Esophageal Cancer.
     Int J Radiat Oncol Biol Phys. 2021 Sep 13. pii: S0360-3016(21)02814.
     PubMed     Abstract available
     
     
     
237. INDELICATO DJ, Dagan R
     A Young Patient with EBV-Positive Nasopharyngeal Carcinoma: Dissonance of Dose, Variance of Volume, and Tussle of Timing.
     Int J Radiat Oncol Biol Phys. 2021;111:9-10.
     PubMed    
     
     
     
238. WU CC, Krasin MJ
     Management of Pediatric Nasopharyngeal Carcinoma: A Role for RT Dose De-escalation.
     Int J Radiat Oncol Biol Phys. 2021;111:11.
     PubMed    
     
     
     
239. MIERZWA M, Beadle BM, Chua MLK, Ma DJ, et al
     Something for Everyone From Low-Risk to High-Risk: 5 Recent Studies to Improve Treatment and Surveillance for All Patients With Squamous Cell Carcinoma of the Head and Neck.
     Int J Radiat Oncol Biol Phys. 2021;111:1-8.
     PubMed    
     
     
     
240. LOIZEAU N, Fabiano S, Papp D, Stutzer K, et al
     Optimal Allocation of Proton Therapy Slots in Combined Proton-Photon Radiation Therapy.
     Int J Radiat Oncol Biol Phys. 2021;111:196-207.
     PubMed     Abstract available
     
     
     August 2021
241. NAZ S, Leiker AJ, Choudhuri R, Preston O, et al
     Pharmacological Inhibition of HSP90 Radiosensitizes Head and Neck Squamous Cell Carcinoma Xenograft by Inhibition of DNA Damage Repair, Nucleotide Metabolism, and Radiation-Induced Tumor Vasculogenesis.
     Int J Radiat Oncol Biol Phys. 2021;110:1295-1305.
     PubMed     Abstract available
     
     
     
242. BISHOP AJ, Livingston JA, Ning MS, Valdez ID, et al
     Young Adult Populations Face Yet Another Barrier to Care With Insurers: Limited Access to Proton Therapy.
     Int J Radiat Oncol Biol Phys. 2021;110:1496-1504.
     PubMed     Abstract available
     
     
     
243. PRASANNA PG, Rawojc K, Guha C, Buchsbaum JC, et al
     Normal Tissue Injury Induced by Photon and Proton Therapies: Gaps and Opportunities.
     Int J Radiat Oncol Biol Phys. 2021;110:1325-1340.
     PubMed     Abstract available
     
     
     June 2021
244. ENGESETH GM, He R, Mirkovic D, Yepes P, et al
     Mixed effect modelling of dose and Linear Energy Transfer correlations with brain image changes after intensity modulated proton therapy for skull base head and neck cancer.
     Int J Radiat Oncol Biol Phys. 2021 Jun 18. pii: S0360-3016(21)00734.
     PubMed     Abstract available
     
     
     
245. ZAHID MU, Mohsin N, Mohamed ASR, Caudell JJ, et al
     Forecasting Individual Patient Response to Radiotherapy in Head and Neck Cancer with a Dynamic Carrying Capacity Model.
     Int J Radiat Oncol Biol Phys. 2021 Jun 5. pii: S0360-3016(21)00676.
     PubMed     Abstract available
     
     
     
246. YOKOTA T, Zenda S, Ota I, Yamazaki T, et al
     Phase 3 randomized trial of topical steroid versus placebo for prevention of radiation dermatitis in head and neck cancer patients receiving chemoradiation.
     Int J Radiat Oncol Biol Phys. 2021 Jun 5. pii: S0360-3016(21)00677.
     PubMed     Abstract available
     
     
     
247. THOMPSON LMA, Donovan KA
     Discussions About Sexual Health: An Unmet Need Among Patients With Human Papillomavirus-Related Oropharyngeal Cancer.
     Int J Radiat Oncol Biol Phys. 2021;110:394-395.
     PubMed    
     
     
     
248. KOTHE A, van Luijk P, Safai S, Kountouri M, et al
     Combining Clinical and Dosimetric Features in a PBS Proton Therapy Cohort to Develop a NTCP Model for Radiation-Induced Optic Neuropathy.
     Int J Radiat Oncol Biol Phys. 2021;110:587-595.
     PubMed     Abstract available
     
     
     
249. TAKEMOTO N, Seo Y, Nakahara S, Yoshioka Y, et al
     Radiation Therapy Alone for Human Papillomavirus-Related Squamous Cell Carcinoma of the Oropharynx: A Single-Arm, Phase 2 Study.
     Int J Radiat Oncol Biol Phys. 2021;110:403-411.
     PubMed     Abstract available
     
     
     
250. WADDLE MR, Ma DJ, Visscher SL, Borah BJ, et al
     Costs of Definitive Chemoradiation, Surgery, and Adjuvant Radiation Versus De-Escalated Adjuvant Radiation per MC1273 in HPV+ Cancer of the Oropharynx.
     Int J Radiat Oncol Biol Phys. 2021;110:396-402.
     PubMed     Abstract available
     
     
     
251. MIERZWA ML, Gharzai LA, Li P, Wilkie JR, et al
     Early MRI Blood Volume Changes in Constrictor Muscles Correlate With Postradiation Dysphagia.
     Int J Radiat Oncol Biol Phys. 2021;110:566-573.
     PubMed     Abstract available
     
     
     
252. CASSWELL G, Gough K, Drosdowsky A, Bressel M, et al
     Sexual Health and Interpersonal Relationships After Chemoradiation Therapy for Human Papillomavirus-Associated Oropharyngeal Cancer: A Cross-sectional Study.
     Int J Radiat Oncol Biol Phys. 2021;110:382-393.
     PubMed     Abstract available
     
     
     May 2021
253. VANDEN BOSCH L, van der Laan HP, van der Schaaf A, Oosting SF, et al
     Patient-reported toxicity and quality of life profiles in head and neck cancer patients treated with definitive radiotherapy or chemoradiation.
     Int J Radiat Oncol Biol Phys. 2021 May 25. pii: S0360-3016(21)00656.
     PubMed     Abstract available
     
     
     
254. WANG L, Gao Z, Li C, Sun L, et al
     Computed tomography-based delta-radiomics analysis for discriminating radiation pneumonitis in patients with esophageal cancer after radiation therapy.
     Int J Radiat Oncol Biol Phys. 2021 May 8. pii: S0360-3016(21)00475.
     PubMed     Abstract available
     
     
     
255. MOLLER DS, Poulsen PR, Hagner A, Dufour M, et al
     Strategies for motion robust proton therapy with pencil beam scanning of esophageal cancer.
     Int J Radiat Oncol Biol Phys. 2021 May 8. pii: S0360-3016(21)00468.
     PubMed     Abstract available
     
     
     
256. VAN DIJK LV, Abusaif AA, Rigert J, Naser MA, et al
     Normal Tissue Complication Probability (NTCP) prediction model for osteoradionecrosis of the mandible in head and neck cancer patients following radiotherapy: Large-scale observational cohort.
     Int J Radiat Oncol Biol Phys. 2021 May 6. pii: S0360-3016(21)00470.
     PubMed     Abstract available
     
     
     
257. GRIMM J, Vargo JA, Mavroidis P, Moiseenko V, et al
     Initial Data Pooling for Radiation Dose-Volume Tolerance for Carotid Artery Blowout and Other Bleeding Events in Hypofractionated Head and Neck Retreatments.
     Int J Radiat Oncol Biol Phys. 2021;110:147-159.
     PubMed     Abstract available
     
     
     April 2021
258. XIAO C, Miller AH, Peng G, Levine ME, et al
     Association of epigenetic age acceleration with risk factors, survival, and quality of life in patients with head and neck cancer.
     Int J Radiat Oncol Biol Phys. 2021 Apr 18. pii: S0360-3016(21)00362.
     PubMed     Abstract available
     
     
     
259. FRANKART AJ, Frankart MJ, Cervenka B, Tang AL, et al
     Osteoradionecrosis: Exposing the Evidence Not the Bone.
     Int J Radiat Oncol Biol Phys. 2021;109:1206-1218.
     PubMed     Abstract available
     
     
     
260. VAN LIMBERGEN EJ, Hoeben A, Lieverse RIY, Houben R, et al
     Toxicity of L19-Interleukin 2 Combined with Stereotactic Body Radiation Therapy: A Phase 1 Study.
     Int J Radiat Oncol Biol Phys. 2021;109:1421-1430.
     PubMed     Abstract available
     
     
     March 2021
261. LUITJE ME, Israel AK, Cummings MA, Giampoli EJ, et al
     Long-Term Maintenance of Acinar Cells in Human Submandibular Glands After Radiation Therapy.
     Int J Radiat Oncol Biol Phys. 2021;109:1028-1039.
     PubMed     Abstract available
     
     
     
262. BUSZEK SM, Ludmir EB, Grosshans DR, McAleer MF, et al
     Disease Control and Patterns of Failure After Proton Beam Therapy for Rhabdomyosarcoma.
     Int J Radiat Oncol Biol Phys. 2021;109:718-725.
     PubMed     Abstract available
     
     
     
263. SHAHI J, Poon I, Ung YC, Tsao M, et al
     Stereotactic Body Radiation Therapy for Mediastinal and Hilar Lymph Node Metastases.
     Int J Radiat Oncol Biol Phys. 2021;109:764-774.
     PubMed     Abstract available
     
     
     
264. DENG J, Dietrich MS, Niermann KJ, Sinard RJ, et al
     Refinement and Validation of the Head and Neck Lymphedema and Fibrosis Symptom Inventory.
     Int J Radiat Oncol Biol Phys. 2021;109:747-755.
     PubMed     Abstract available
     
     
     February 2021
265. LIU WS, Tsai KW, Kang BH, Yang CC, et al
     Simultaneous Reduction of Volume and Dose in Clinical Target Volume for Nasopharyngeal Cancer Patients.
     Int J Radiat Oncol Biol Phys. 2021;109:495-504.
     PubMed     Abstract available
     
     
     January 2021
266. MCDOWELL L, Rischin D, Lee AWM
     Locoregional Radiation Therapy for De Novo Metastatic Nasopharyngeal Cancer: One Size Fits All?
     Int J Radiat Oncol Biol Phys. 2021;109:131-133.
     PubMed    
     
     
     
267. ANKER CJ, Dragovic J, Herman JM, Bianchi NA, et al
     Executive Summary of the American Radium Society Appropriate Use Criteria for Operable Esophageal and Gastroesophageal Junction Adenocarcinoma: Systematic Review and Guidelines.
     Int J Radiat Oncol Biol Phys. 2021;109:186-200.
     PubMed     Abstract available
     
     
     December 2020
268. FANG P, Gunther JR, Pinnix CC, Dong W, et al
     A Prospective Trial of Radiation Therapy Efficacy and Toxicity for Localized Mucosa-associated Lymphoid Tissue (MALT) Lymphoma.
     Int J Radiat Oncol Biol Phys. 2020 Dec 9. pii: S0360-3016(20)34644.
     PubMed     Abstract available
     
     
     
269. MOHAMED ASR, He R, Ding Y, Wang J, et al
     Quantitative Dynamic Contrast-Enhanced MRI Identifies Radiation-Induced Vascular Damage in Patients With Advanced Osteoradionecrosis: Results of a Prospective Study.
     Int J Radiat Oncol Biol Phys. 2020;108:1319-1328.
     PubMed     Abstract available
     
     
     November 2020
270. DYER BA, Mayadev JS
     Restage and Chemoradiation.
     Int J Radiat Oncol Biol Phys. 2020;108:849-850.
     PubMed    
     
     
     
271. MOWERY YM, Vergalasova I, Rushing CN, Choudhury KR, et al
     Early (18)F-FDG-PET Response During Radiation Therapy for HPV-Related Oropharyngeal Cancer May Predict Disease Recurrence.
     Int J Radiat Oncol Biol Phys. 2020;108:969-976.
     PubMed     Abstract available
     
     
     
272. CHOU WC, Yeh KY, Chang PH, Lu CH, et al
     In Reply to Chow et al.
     Int J Radiat Oncol Biol Phys. 2020;108:832-834.
     PubMed    
     
     
     
273. CHOW JCH, Cheung KM, Bao KKH, Leung AKC, et al
     In Regard to Chou et al.
     Int J Radiat Oncol Biol Phys. 2020;108:831-832.
     PubMed    
     
     
     
274. DHARMARAJAN KV, Mohile SG
     Can Geriatric Assessment Measures Be Used to Determine Cancer Treatment Vulnerability in Nongeriatric Patients?
     Int J Radiat Oncol Biol Phys. 2020;108:612-614.
     PubMed    
     
     
     
275. PRICE JG, Spiegel DY, Yoo DS, Moravan MJ, et al
     Development and Implementation of an Educational Simulation Workshop in Fiberoptic Laryngoscopy for Radiation Oncology Residents.
     Int J Radiat Oncol Biol Phys. 2020;108:615-619.
     PubMed     Abstract available
     
     

Thank you for your interest in scientific medicine.

AMEDEO Head and Neck Cancer is free of charge.